LINCOLN PHARMACEUTICALS LTD. - Board Meeting Intimation for Inter-Alia To Consider And Approve The Audited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2022

LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve audited (standalone and consolidated) financial results of the Company for the quarter and year ended on March 31, 2022